UNSPSC 85594644: Supplement ileum with nonautologous tissue substitute, via natural or artificial opening

This classification denotes the group of activities that yields a surgical intervention or procedure to supplement ileum with nonautologous tissue substitute, via natural or artificial opening. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DUB7KZ

UNSPSC 85594644 Supplement ileum with nonautologous tissue substitute, via natural or artificial opening is a Commodity code that does not align with recent state and local procurement activity. The code describes a clinical surgical procedure, but the most-recent opportunities posted under this code cover medical staffing, pharmacy benefit management, occupational health surveillance, disability medical evaluations, and surgical care coordination — none of which involve ileal supplementation with tissue substitutes. The mismatch indicates that either the code has been applied incorrectly to administrative or procurement-adjacent healthcare services, or the code sees limited relevant activity in state and local procurement channels.

Recent opportunities across Arizona, California, Florida, and Washington show state and local health systems, retirement boards, and county governments soliciting healthcare administration and staffing services rather than clinical procedures. Representative recent solicitations include the City of Phoenix Retirement Office's RFP for independent medical evaluation services (RTMRFP26001, due October 16, 2026), the City of Long Beach's RFP for surgical care carve-out benefits management (HR26753, due October 7, 2026), the Washington State Department of Transportation's RFP for occupational medical surveillance (RFP20260825, due October 9, 2026), and the County of Santa Clara Health System's solicitation to establish a qualified vendor pool for temporary health professional staffing (RFSQHHSFY270052, due October 7, 2026). No opportunities in the source material involve tissue-substitute medical devices or surgical implants aligned with the code's nominal scope.